As a biotech company co-founded by scientists from Novo Nordisk China R&D Center, Sino-American Champion and Shanghai Jiao Tong University Institute of Immunology, InnoModels Biotechnology (Beijing) Co., Ltd. has demonstrated outstanding strength in biotechnology, especially in immunology and disease diagnostics. Among them, InnoModels' ELISA (Enzyme Linked Immunosorbent Assay) platform has been widely used and recognized in biomedical research, disease diagnosis and drug discovery and development with its unique advantages.
Sensitivity and Specificity
The primary advantage of the ELISA platform is its high sensitivity and specificity. In the ELISA method of enzyme activity amplification, the sensitivity of the assay far exceeds that of the traditional RIA (radioimmunoassay) technique, and is capable of capturing very low concentrations of target proteins or antibodies. This high degree of sensitivity not only ensures the accuracy of the test results, but also makes the platform valuable in applications such as early disease diagnosis and drug efficacy monitoring. Meanwhile, ELISA technology increases the specificity of the detection process through the specificity of the enzyme-substrate reaction, effectively avoiding the interference of non-specific signals.
Easy to operate and low cost
Another significant advantage of the ELISA platform is its simplicity and cost-effectiveness. Compared with other high-end detection technologies, ELISA experiments require relatively simple instruments and equipment, including a spiker, incubator, and enzyme-specific readers, which can be configured in an ordinary laboratory. In addition, the cost of ELISA kits is relatively low, and due to the stability of the reaction system, the reagents can be stored for a long time under low temperature or dry conditions, which reduces the cost of the experiment. What's more, the ELISA process is simple, with no need for complicated sample pre-treatment steps, and preliminary results can be obtained within minutes, greatly improving experimental efficiency.
Wide range of applications to meet diversified needs
InnoModels Bio's ELISA platform is not only limited to a specific field of application, but also demonstrates a wide range of adaptability. In biomedical research, ELISA technology can be used to quantitatively detect specific proteins or antibodies in serum, plasma or other body fluids, providing important data support for disease mechanism research and drug target screening. In the field of clinical diagnosis, ELISA platform can be used for early diagnosis, disease monitoring and prognosis assessment of various diseases. In addition, ELISA technology can be used to assess the impact of drugs on the immune system during drug development, providing an important basis for drug safety and efficacy evaluation.

Contributing to tumor and immunotherapy research
It is especially worth mentioning that with its stable domestic platforms for humanized immune system mice (HIS) and human tumor xenografts (PDX), InnoModels has a significant advantage in the field of oncology and tumor immunopharmacodynamics CRO services, and the combination of the ELISA platform and these platforms provides a new generation of experimental animal models that are close to the clinic for the research and development of oncology and tumor immunotherapies. The ELISA platform, in combination with these platforms, provides a new generation of experimental animal models close to the clinic for tumor and tumor immunotherapy research and development. In the fields of tumor vaccine research and immune checkpoint inhibitor development, the ELISA platform provides an important reference for the effectiveness and safety assessment of therapeutic methods by accurately detecting and analyzing the activity and number of specific immune cells in patients.
Conclusion
In summary, with its advantages of high sensitivity, high specificity, easy operation and high cost-effectiveness, InnoModels' ELISA platform has shown great potential for application in various fields such as biomedical research, disease diagnosis and drug discovery. In the future, with the continuous progress and innovation of technology, we believe that ELISA platform will play an important role in more fields and make greater contributions to human health.